Since its establishment in 2011 in Seoul, South Korea, AIOBIO has gained widespread recognition within both clinical practices and academic circles across the country for its pioneering Biofluorescence Detection Technology-based devices. Notably, AIOBIO’s efforts have led to the inclusion of its products in the National Health Insurance coverage for caries detection among children in South Korea.

Healthcare is inherently rooted in local contexts. Drawing from over three decades of experience, Dr. Yoon, DDS, DMD, and his proficient team have navigated the intricacies of the Korean dental health system, demonstrating a steadfast commitment to continuous improvement over the span of more than ten years. These cumulative efforts have contributed to the substantial reservoir of knowledge and insights that form the foundation of AIOBIO’s expertise.

In a carefully calculated manner, AIOBIO USA has strategically established its presence in the United States. With a profound understanding of the multifaceted nuances intrinsic to the healthcare landscape, encompassing regulatory intricacies, financial dynamics, and the intricacies of vested interests, AIOBIO USA embarked on its American journey. AIOBIO USA’s approach has involved forging connections with key local stakeholders, both horizontally and vertically, within the healthcare domain, reflecting its comprehensive grasp of the interwoven fabric of the healthcare ecosystem.